{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:35:36Z","timestamp":1792236936850,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1124\/dmd.108.020545","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:36:04Z","timestamp":1205195764000},"page":"1016-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug"],"prefix":"10.1016","volume":"36","author":[{"given":"Jonathan N.","family":"Bauman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosea S.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Walsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Obach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Kalgutkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.020545_bib1","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1056\/NEJM200311133492021","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Andrade","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.108.020545_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/tx0501637","article-title":"Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"18","author":"Argoti","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.020545_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bms.1200220602","article-title":"Mass spectrometry in the analysis of glutathione conjugates","volume":"22","author":"Baillie","year":"1993","journal-title":"Biol Mass Spectrom"},{"key":"10.1124\/dmd.108.020545_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-9556(25)07249-6","article-title":"Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans","volume":"24","author":"Barbhaiya","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/dmd.31.3.289","article-title":"Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine","volume":"31","author":"Bertelsen","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2174\/138920007781368908","article-title":"N-Dealkylation of arylpiprazine derivatives: Disposition and metabolism of the 1-arylpiperazines formed","volume":"8","author":"Caccia","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.108.020545_bib7","first-page":"1187","article-title":"Nefazodone (serzone) withdrawn because of hepatotoxicity","volume":"169","author":"Choi","year":"2003","journal-title":"CMAJ"},{"key":"10.1124\/dmd.108.020545_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.020545_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4088\/JCP.v63n0208","article-title":"Hepatotoxicity associated with the new antidepressants","volume":"63","author":"Garc\u00eda-Pando","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.108.020545_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003088-199733040-00002","article-title":"Clinical pharmacokinetics of nefazodone","volume":"33","author":"Greene","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.108.020545_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1289\/ehp.834971","article-title":"Reactive metabolites of phenacetin and acetaminophen: a review","volume":"49","author":"Hinson","year":"1983","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.108.020545_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425255.1.1.91","article-title":"Minimising the potential for metabolic activation in drug discovery","volume":"1","author":"Kalgutkar","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.108.020545_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A comprehensive listing of bioactivation pathways of organic functional groups","volume":"6","author":"Kalgutkar","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.108.020545_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/dmd.104.001735","article-title":"Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4","volume":"33","author":"Kalgutkar","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib15","first-page":"663","article-title":"Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates","volume":"25","author":"Kitani","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib16","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1002\/rcm.3303","article-title":"Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms","volume":"21","author":"Li","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.108.020545_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0091270003261901","article-title":"Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers","volume":"44","author":"Mallikaarjun","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.108.020545_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0090-9556(25)08374-6","article-title":"Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma","volume":"22","author":"Mayol","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.ftd.0000249944.42859.bf","article-title":"Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients","volume":"28","author":"Molden","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.108.020545_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4615-0667-6_4","article-title":"Structure toxicity relationships\u2013how useful are they in predicting toxicities of new drugs?","volume":"500","author":"Nelson","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/dmd.108.020545_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.020545_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.pharmtox.45.120403.100058","article-title":"The role of metabolic activation in drug-induced hepatotoxicity","volume":"45","author":"Park","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.020545_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jasms.2005.11.014","article-title":"Application of a linear ion trap\/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements","volume":"17","author":"Peterman","year":"2006","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1124\/dmd.108.020545_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/070674370204700409","article-title":"Hepatic adverse reactions with nefazodone","volume":"47","author":"Stewart","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1124\/dmd.108.020545_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/tx600277y","article-title":"Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry","volume":"20","author":"Zheng","year":"2007","journal-title":"Chem Res Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624016738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624016738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.020545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:23:27Z","timestamp":1739895807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624016738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0090955624016738"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.020545","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.020545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}